nor-NOHA Uses, Dosage, Side Effects and more
N-Hydroxy-nor-L-arginine (nor-NOHA) is under investigation in clinical trial NCT02009527 (Arginase Inhibition in Ischemia-reperfusion Injury).
| Attribute | Details |
|---|---|
| Trade Name | nor-NOHA |
| Generic | nor-NOHA |
| Type | |
| Formula | C5H12N4O3 |
| Weight | Average: 176.1738 Monoisotopic: 176.09094027 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
